-
Product Insights
Serine/Threonine Protein Kinase ATR – Drugs In Development, 2023
Global Markets Direct’s Serine/Threonine Protein Kinase ATR provides in depth analysis on Serine/Threonine Protein Kinase ATR targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Serine/Threonine Protein Kinase...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATRN-119 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATRN-119 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATRN-119 in Non-Small Cell Lung Cancer Drug Details: ATRN-119 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATRN-119 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATRN-119 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATRN-119 in Breast Cancer Drug Details: ATRN-119 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATRN-119 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATRN-119 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATRN-119 in Colorectal Cancer Drug Details: ATRN-119 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATRN-119 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATRN-119 in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATRN-119 in Pancreatic Cancer Drug Details: ATRN-119 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATRN-119 in Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATRN-119 in Adrenocortical Carcinoma (Adrenal Cortex Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATRN-119 in Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATRN-119 in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATRN-119 in Fallopian Tube Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATRN-119 in Fallopian Tube Cancer Drug Details: ATRN-119 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATRN-119 in Duodenal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATRN-119 in Duodenal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATRN-119 in Duodenal Cancer Drug Details: ATRN-119 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATRN-119 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATRN-119 in Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATRN-119 in Ovarian Cancer Drug Details: ATRN-119 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATRN-119 in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATRN-119 in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATRN-119 in Prostate Cancer Drug Details: ATRN-119 is under development for the...